AnaptysBio, Inc.

AnaptysBio, Inc.

AnaptysBio, Inc.

Overview
Date Founded

2005

Headquarters

10421 Pacific Center Court, Suite 200, San Diego, CA, 92121, USA

Type of Company

Public

Employees (Worldwide)

94

Industries

Biotechnology
Pharmaceuticals
Hospitals & Patient Services

Company Description

AnaptysBio, Inc. is a clinical stage biotechnology company, which engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. It also offers SHM platform that replicate the natural process of somatic hypermutation embedded within the human immune system to rapidly develop a diverse range of therapeutic-grade antibodies in vitro. The company was founded by Andrew B. Cubitt, William J. Boyle, Kevin J. Kinsella, and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.

Contact Data
Trying to get in touch with decision makers at AnaptysBio, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Chief Financial Officer & Principal Accounting Officer

Chief Operating Officer & General Counsel

Chief Medical Officer

Vice President, Controller

Senior Vice President, Human Resources

Senior Vice President, Project Management

Vice President, Molecular Biology & Protein Sciences

Vice President, Cell Biology

Vice President, Toxicology & Pharmacology

Paths to AnaptysBio, Inc.
Potential Connections via
Relationship Science
You
AnaptysBio, Inc.
Owners & Shareholders
Details Hidden

Ecor1 invests (long and short) in securities, consisting principally, but not solely, of equity and equity-related securities that are issued by biotechnology companies globally.

Details Hidden

Tang Capital focuses on investments in small-cap US companies in the life sciences sector.

Details Hidden

Tavistock Life Sciences invests in a portfolio of public companies and private equity crossover opportunities. Investments tend to focus on focus on biotechnology drug development companies across multiple therapeutic indications.

Recent Transactions
Details Hidden

AnaptysBio, Inc. issued USD Common Stock

Details Hidden

AnaptysBio, Inc. issued USD Common Stock

Details Hidden

AnaptysBio, Inc. issued USD Common Stock

Transaction Advisors
Escrow Agent

Advised onAnaptysBio, Inc. issued USD Common Stock

Underwriter

Advised onAnaptysBio, Inc. issued USD Common Stock

Auditor

Advised onAnaptysBio, Inc. issued USD Common Stock

Legal Advisor

Advised onAnaptysBio, Inc. issued USD Common Stock

Legal Advisor

Advised onAnaptysBio, Inc. issued USD Common Stock

Co-Chair, Securities & Corporate Finance Practice

Advised onAnaptysBio, Inc. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Partner, San Diego at Cooley LLP

Legal Advisor

Partner, Palo Alto at Cooley LLP

Publicist

Head-Public & Investor Relations at M3 Biotechnology, Inc.

Clients

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon O. Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA.

Key Stats and Financials As of 2020
Market Capitalization
$695M
Total Enterprise Value
$194M
Earnings Per Share
$-0.73
Revenue
$75M
EBITDAMargin
-31.09%
Total Debt
$342K
Net Profit
$-19.9M
EBITDA
$-23.3M
Total Equity
$397M
Enterprise Value / Sales
2.58x
TEVNet Income
-9.72x
Debt TEV
0x
Three Year Compounded Annual Growth Rate Of Revenue
95.74%
Investors
Details Hidden

Frazier Management invests in companies located in the US with an EBITDA of $5 - $50 million. The firm focuses on companies operating in the fields of Life Science, pharmaceuticals and healthcare services. They provides financing for mezzanine, late private/public opportunities, seed, early and later stage, buyouts, recapitalizations and corporate carve-outs with an investment size of $30 - $350 million.

Details Hidden

BioMed Ventures is an active manager invests in life science industries companies. The firm focus on broad range sectors includes drug discovery, drug development, diagnostics, tools and medical devices. It provides financing for growth stage capital requirements.

Details Hidden

Founder at Avalon Ventures Management LLC

Suppliers
Merck KGaA Hospitals & Patient Services | Darmstadt, Germany

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

UK Research & Innovation Biotechnology | London, United Kingdom

UK Research & Innovation (doing business as United Kingdom Research & Innovation) is a private company headquartered in London, UK, that provides science and technology research services.The company says this about itself: Innovate UK is part of UK Research and Innovation, a non-departmental public body funded by a grant-in-aid from the UK government. We drive productivity and economic growth by supporting businesses to develop and realise the potential of new ideas, including those from the UK’s world-class research base.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government. Johnson & Johnson is headquartered in New Brunswick, New Jersey, the consumer division being located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in 60 countries and products sold in over 175 countries. Johnson & Johnson had worldwide sales of $82.6 billion during calendar year 2020. Johnson & Johnson's brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's Baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses. Johnson & Johnson's pharmaceutical arm is Janssen Pharmaceutica.

Regeneron Pharmaceuticals, Inc. Pharmaceuticals - Tarrytown, New York

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

GlaxoSmithKline Plc Pharmaceuticals - Brentford, Gbr

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by AnaptysBio, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of AnaptysBio, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and AnaptysBio, Inc..